Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-09

Clinical Trial Update: Safety of Lymph Node Injection for Allergen Immunotherapy [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the safety of lymph node injections for allergen immunotherapy in allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Amber Patterson | Conditions: Allergic Rhinitis | Phase 1 | Status: UNKNOWN